Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Enhanced recovery after surgery components and perioperative outcomes: a nationwide observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Use of the GRADE approach in systematic reviews and guidelines

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  3. High-dose naloxone, an experimental tool uncovering latent sensitisation: pharmacokinetics in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Chlorhexidine allergy in the perioperative setting: a narrative review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

BACKGROUND: /st> The role of nitrous oxide in modern anaesthetic practice is contentious. One concern is that exposure to nitrous oxide may increase the risk of cardiovascular complications. ENIGMA II is a large randomized clinical trial currently underway which is investigating nitrous oxide and cardiovascular complications. Before the completion of this trial, we performed a systematic review and meta-analysis, using Cochrane methodology, on the outcomes that make up the composite primary outcome.

METHODS: /st> We used conventional meta-analysis and trial sequential analysis (TSA). We reviewed 8282 abstracts and selected 138 that fulfilled our criteria for study type, population, and intervention. We attempted to contact the authors of all the selected publications to check for unpublished outcome data.

RESULTS: /st> Thirteen trials had outcome data eligible for our outcomes. We assessed three of these trials as having a low risk of bias. Using conventional meta-analysis, the relative risk of short-term mortality in the nitrous oxide group was 1.38 [95% confidence interval (CI) 0.22-8.71] and the relative risk of long-term mortality in the nitrous oxide group was 0.94 (95% CI 0.80-1.10). In both cases, TSA demonstrated that the data were far too sparse to make any conclusions. There were insufficient data to perform meta-analysis for stroke, myocardial infarct, pulmonary embolus, or cardiac arrest.

CONCLUSION: /st> This systematic review demonstrated that we currently do not have robust evidence for how nitrous oxide used as part of general anaesthesia affects mortality and cardiovascular complications.

OriginalsprogEngelsk
TidsskriftBritish Journal of Anaesthesia
Vol/bind112
Udgave nummer3
Sider (fra-til)410-26
Antal sider17
ISSN0007-0912
DOI
StatusUdgivet - mar. 2014

ID: 43733916